EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson’s Disease: A Randomized Controlled Trial

Carley Rusch iD, Matthew Beke, Carmelo Nieves, Volker Mai iD, Tamara Stiep iD, Tracy Tholanikunnel, Adolfo Ramirez-Zamora iD, Christopher W Hess, Bobbi Langkamp-Henken iD

Nutrients · 02.09.2024 · 16 (17) · 2946

DOI: 10.3390/nu16172946 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 02.09.2024. Verfasst von Carley Rusch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Food Science and Human Nutrition Department, Center for Nutritional Sciences, University of Florida, Gainesville, FL 32611-0370, USA. Hauptthemen laut MEDLINE: Constipation, Leukocyte L1 Antigen Complex, Feces, Diet, Mediterranean. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: USDA National Institute of Food and Agriculture Hatch, Fixel Family Foundation, Lauren and Lee Fixel Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease is associated with gastrointestinal (GI) dysfunction, including constipation symptoms and abnormal intestinal permeability and inflammation. A Mediterranean diet (MediDiet) may aid in disease management. This parallel, randomized, controlled trial in people with Parkinson’s (PwP) and constipation symptoms compared a MediDiet against standard of care on change in constipation symptoms, dietary intake, and fecal zonulin and calprotectin concentrations as markers of intestinal permeability and inflammation, respectively. Participants were randomized to either standard of care for constipation (control; n = 17, 65.1 ± 2.2 years) or a MediDiet plus standard of care (n = 19, 68.8 ± 1.4 years) for 8 weeks. Constipation scores decreased with both interventions (p < 0.01), but changes from baseline were not different between groups (MediDiet, −0.5 [−1.0, 0]; control, −0.8 [−1.0, 0.2]; median [25th, 75th]; p = 0.60). The MediDiet group had a higher intake of dietary fiber at week 4 than the control group (13.1 ± 0.7 g/1000 kcal vs. 9.8 ± 0.7 g/1000 kcal; p < 0.001). No differences in fecal zonulin were observed between groups (p = 0.33); however, fecal calprotectin tended to be lower in the MediDiet group at week 8 (45.8 ± 15.1 µg/g vs. 93.9 ± 26.8 µg/g; p = 0.05). The MediDiet and standard interventions reduced constipation symptoms; however, the MediDiet provided additional benefit of increased dietary fiber intake and less intestinal inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConstipationLeukocyte L1 Antigen ComplexFecesDiet, MediterraneanParkinson DiseaseHumansMaleFemaleAgedMiddle AgedBiomarkersHaptoglobinsDietary FiberProtein Precursors

Stichwörter der Autor:innen

Mediterranean dietParkinson’s diseaseconstipationinflammationmicrobiota

Substanzen

Leukocyte L1 Antigen ComplexzonulinBiomarkersHaptoglobinsDietary FiberProtein Precursors

Autor:innen und Institutionen

  • Food Science and Human Nutrition Department, Center for Nutritional Sciences, University of Florida, Gainesville, FL 32611-0370, USA.
  • Department of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL 32610-0236, USA.
  • Department of Epidemiology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610-0009, USA.

ORCID-Profile: Carley Rusch, Volker Mai, Tamara Stiep, Adolfo Ramirez-Zamora, Bobbi Langkamp-Henken

Förderung

  • USDA National Institute of Food and Agriculture Hatch
  • Fixel Family Foundation
  • Lauren and Lee Fixel Family Foundation

Zitieren

APA

Rusch, C., Beke, M., Nieves, C., Mai, V., Stiep, T., Tholanikunnel, T., Ramirez-Zamora, A., Hess, C. W., & Langkamp-Henken, B. (2024). Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson’s Disease: A Randomized Controlled Trial. Nutrients, 16(17), 2946. https://doi.org/10.3390/nu16172946

Vancouver

Rusch C, Beke M, Nieves C, Mai V, Stiep T, Tholanikunnel T, et al. Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson’s Disease: A Randomized Controlled Trial. Nutrients. 2024;16(17):2946. doi:10.3390/nu16172946

BibTeX
@article{Rusch2024,
  author = {Rusch, Carley and Beke, Matthew and Nieves, Carmelo and Mai, Volker and Stiep, Tamara and Tholanikunnel, Tracy and Ramirez-Zamora, Adolfo and Hess, Christopher W and Langkamp-Henken, Bobbi},
  title = {Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson’s Disease: A Randomized Controlled Trial},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {17},
  pages = {2946},
  doi = {10.3390/nu16172946}
}
Kostenlos starten →